190 related articles for article (PubMed ID: 30817047)
1. Viral hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice.
Te H; Doucette K
Clin Transplant; 2019 Sep; 33(9):e13514. PubMed ID: 30817047
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations.
Torres HA; Chong PP; De Lima M; Friedman MS; Giralt S; Hammond SP; Kiel PJ; Masur H; McDonald GB; Wingard JR; Gambarin-Gelwan M
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1870-82. PubMed ID: 26256943
[No Abstract] [Full Text] [Related]
3. Human T-cell lymphotrophic virus in solid-organ transplant recipients: Guidelines from the American society of transplantation infectious diseases community of practice.
Kaul DR; Sharma TS;
Clin Transplant; 2019 Sep; 33(9):e13575. PubMed ID: 31021486
[TBL] [Abstract][Full Text] [Related]
4. Arenaviruses and West Nile Virus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Anesi JA; Silveira FP;
Clin Transplant; 2019 Sep; 33(9):e13576. PubMed ID: 31022306
[TBL] [Abstract][Full Text] [Related]
5. Solid organ transplantation in the HIV-infected patient: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Blumberg EA; Rogers CC;
Clin Transplant; 2019 Sep; 33(9):e13499. PubMed ID: 30773688
[TBL] [Abstract][Full Text] [Related]
6. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Allen UD; Preiksaitis JK;
Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipients.
Taneja S; Duseja A; De A; Kumar V; Ramachandran R; Sharma A; Dhiman RK; Gupta KL; Chawla Y
Nephrology (Carlton); 2018 Sep; 23(9):876-882. PubMed ID: 28703905
[TBL] [Abstract][Full Text] [Related]
8. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Selçuk H; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():159-64. PubMed ID: 25894147
[TBL] [Abstract][Full Text] [Related]
9. Implications of Treating Hepatitis C Virus Infection Among Patients Awaiting Cadaveric Liver Transplant: A Single-Center Experience.
Ofosu A; Durand CM; Saberi B; Alqahtani S; Ucbilek E; Belden M; Cameron AM; Gurakar A
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():7-10. PubMed ID: 26640901
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.
Bhamidimarri KR; Ladino M; Pedraza F; Guerra G; Mattiazzi A; Chen L; Ciancio G; Kupin W; Martin P; Burke G; Roth D
Transpl Int; 2017 Sep; 30(9):865-873. PubMed ID: 28332729
[TBL] [Abstract][Full Text] [Related]
11. A local experience of treatment response in chronic hepatitis C infection.
Bijani B; Ghanei L; Kazemifar AM
Infez Med; 2015 Dec; 23(4):343-8. PubMed ID: 26700085
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C Virus Eradication with New Interferon-Free Treatment Improves Metabolic Profile in Hepatitis C Virus-Related Liver Transplant Recipients.
Beig J; Orr D; Harrison B; Gane E
Liver Transpl; 2018 Aug; 24(8):1031-1039. PubMed ID: 29577581
[TBL] [Abstract][Full Text] [Related]
13. Management of Viral Hepatitis in Solid Organ Transplant Recipients.
Buganza-Torio E; Doucette KE
Infect Dis Clin North Am; 2018 Sep; 32(3):635-650. PubMed ID: 30146027
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Florescu DF; Schaenman JM;
Clin Transplant; 2019 Sep; 33(9):e13527. PubMed ID: 30859626
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.
Razonable RR; Humar A
Clin Transplant; 2019 Sep; 33(9):e13512. PubMed ID: 30817026
[TBL] [Abstract][Full Text] [Related]
16. Screening of donor and candidate prior to solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Malinis M; Boucher HW;
Clin Transplant; 2019 Sep; 33(9):e13548. PubMed ID: 30900327
[TBL] [Abstract][Full Text] [Related]
17. The effect of pretransplant chronic hepatitis C virus infection treatment on graft and patient survival in renal transplant recipients.
Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Ensaroğlu F; Selçuk H; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():188-92. PubMed ID: 25894152
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C viraemic organs in solid organ transplantation.
Weinfurtner K; Reddy KR
J Hepatol; 2021 Mar; 74(3):716-733. PubMed ID: 33212088
[TBL] [Abstract][Full Text] [Related]
19. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
[TBL] [Abstract][Full Text] [Related]
20. First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder.
Al Nahdi N; Ford JA; Greanya ED; Harrigan JA; Tse I; Steinbrecher UP; Erb SR; Yoshida EM
Ann Hepatol; 2013; 12(1):156-60. PubMed ID: 23293209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
